Differential effects of neuropeptide Y and the μ-agonist DAMGO on 'palatability' vs. 'energy'

Brain Research

Volumn 834, Issue 1-2, 1999, Pages 160-163

  Giraudo, Silvia Q ^a,b,d   Grace, Martha K ^b   Billington, Charles J ^a,b,c   Levine, Allen S ^a,b,c,d  

^a University of Minnesota   (United States)

^b VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

DAMGO; Neuropeptide Y; Paraventricular nucleus; Sucrose

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR AGONIST; NEUROPEPTIDE Y;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CALORIC INTAKE; ENERGY METABOLISM; FEEDING; MALE; NONHUMAN; PALATABILITY; PRIORITY JOURNAL; RAT; REWARD; THALAMUS MIDLINE NUCLEUS;

ANIMAL FEED; ANIMALS; ENERGY INTAKE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; FOOD PREFERENCES; INJECTIONS; MALE; NEUROPEPTIDE Y; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SOLUTIONS; SUCROSE; TASTE;

EID: 0033542775     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01512-7     Document Type: Article

References (31)

1. Bertino M., Beauchamp G.K., Engelman K. Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. American Journal of Physiology. 261:1991;R59-R63.
2. Billington C.J., Briggs J.E., Harker S., Grace M., Levine A.S. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. American Journal of Physiology. 266:1994;R1765-R1770.
3. Brady L.S., Smith M.A., Gold P.W., Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology. 52:1990;441-447.
4. Cooper S., Turkish S. Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats. Pharmacology, Biochemistry and Behavior. 33:1989;17-20.
5. Cooper S.J. Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat. Neuropharmacology. 22:1983;323-328.
6. Cooper S.J., Jackson A., Kirkham T.C. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia. Pharmacology, Biochemistry and Behavior. 23:1985;889-901.
7. S.J. Cooper, A. Jackson, T.C. Kirkham, S. Turkish, Endorphins, opiates and food intake, in: R.J. Rodgers, S.J. Cooper (Eds.), Endorphins, Opiates and Behavioural Processes. Wiley, London, 1988, pp. 143-186.
8. Drewnowski A., Krahn D.D., Demitrack M.A., Nairn K., Gosnell B.A. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiology and Behavior. 51:1992;371-379.
9. Fantino M., Hosotte J., Apfelbaum M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. American Journal of Physiology. 251:1986;R91-R96.
10. Jewett D.C., Cleary J., Levine A.S., Schaal D.W., Thompson T. Effects of neuropeptide Y on food-reinforced behavior in satiated rats. Pharmacology, Biochemistry and Behavior. 42:1992;207-212.
11. Jewett D.C., Cleary J., Levine A.S., Schaal D.W., Thompson T. Effects of neuropeptide Y, insulin, 2-deoxyglucose, and food deprivation on food-motivated behavior. Psychopharmacology. 120:1995;267-271.
12. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proceedings of the National Academy of Sciences of the United States of America. 88:1991;10931-10935.
13. Kim E.-M., Welch C.C., Grace M.K., Billington C.J., Levine A.S. Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in the arcuate nucleus. American Journal of Physiology. 270:1996;R1019-R1024.
14. Kotz C.M., Billington C.J., Levine A.S. Opioids in the nucleus of the solitary tract are involved in feeding in the rat. American Journal of Physiology Regulatory Integrative and Comparative Physiology. 41:1997;R1028-R1032.
15. Kotz C.M., Grace M.K., Briggs J., Levine A.S., Billington C.J. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. Journal of Clinical Investigation. 96:1995;163-170.
16. Levine A.S., Atkinson R.L. Opioids in the regulation of food intake and energy expenditure. Federation Proceedings. 46:1987;159-162.
17. Levine A.S., Billington C.J. Opioids: are they regulators of feeding? Annals of the New York Academy of Sciences. 575:1989;209-219.
18. Levine A.S., Grace M., Billington C.J. The effect of centrally administered naloxone on deprivation and drug-induced feeding. Pharmacology, Biochemistry and Behavior. 36:1990;409-412.
19. Levine A.S., Morley J.E. Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides. 5:1984;1025-1029.
20. Levine A.S., Morley J.E., Gosnell B.A., Billington C.J., Bartness T.J. Opioids and consummatory behavior. Brain Res. Bull. 14:1985;663-672.
21. Levine A.S., Morley J.E., Gosnell B.A., Billington C.J., Krahn D.D. Neuropeptides as regulators of consummatory behaviors. Journal of Nutrition. 116:1986;2067-2077.
22. Levine A.S., Murray S.S., Kneip J., Grace M., Morley J.E. Flavor enhances the antidipsogenic effect of naloxone. Physiology and Behavior. 28:1982;23-25.
23. Levine A.S., Weldon D.T., Grace M., Cleary J.P., Billington C.J. Naloxone blocks that portion of feeding driven by sweet taste in food restricted rats. American Journal of Physiology. 268:1995;R248-R252.
24. Lynch W.C., Grace M., Billington C.J., Levine A.S. Effects of neuropeptide Y on ingestion of flavored solutions in nondeprived rats. Physiology and Behavior. 54:1993;877-880.
25. Lynch W.C., Hart P., Babcock A.M. Neuropeptide Y attenuates satiety: evidence from a detailed analysis of patterns ingestion. Brain Research. 636:1994;28-34.
26. Lynch W.C., Libby L. Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and satiated rats. Life Sciences. 33:1983;1909-1914.
27. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates. San Diego, Academic Press, 1986.
28. Reid L.D. Endogenous opioid peptides and regulation of drinking and feeding. American Journal of Clinical Nutrition. 42:1985;1099-1132.
29. Welch C.C., Kim E.-M., Grace M.K., Billington C.J., Levine A.S. Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Research. 721:1996;126-131.
30. White J., Kershaw M., Sanacora G., Olchovsky D., Finkelstein J., Berelowitz M. Hypothalamic neuropeptide Y expression in normal and aberrant metabolic homeostasis. Annals of the New York Academy of Sciences. 611:1990;480-482.
31. White J.D., Olchovsky D., Kershaw M., Berelowitz M. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology. 126:1990;765-772.